Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
- NAV / 1-Day Return 33.90 / 0.62 %
- Total Assets 864.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.310%
- Distribution Fee Level High
- Share Class Type No Load
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,000
- Status Open
- TTM Yield —
- Turnover 23%
Morningstar’s Analysis BIOPX
Will BIOPX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
Process Pillar
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings 49
- Bond Holdings 0
- Other Holdings 5
- % Assets in Top 10 Holdings 53.1